Assess whether the carve-out is operable on day one (aab779)

SITUATION Regulatory-approval critical-path calendar arrived with a QoE that cannot tie revenue to bank cash for integration-risk PMO. That is a M&A Due Diligence Legal, IP, and Regulatory decision on the carve-out is operable in a roll-up of three regional service companies.

DECISION Integration-risk PMO in a roll-up of three regional service companies must choose Proceed / Reprice / Walk / Hold using regulatory-approval critical-path calendar after a QoE that cannot tie revenue to bank cash.

HYPOTHESES TO TEST 1. The population in regulatory-approval critical-path calendar is the one a QoE that cannot tie revenue to bank cash named, so Proceed follows for this Legal, IP, and Regulatory file. 2. The population in regulatory-approval critical-path calendar is adjacent only to a QoE that cannot tie revenue to bank cash; Reprice is the honest M&A Due Diligence call. 3. A roll-up of three regional service companies already contained a QoE that cannot tie revenue to bank cash before regulatory-approval critical-path calendar arrived; no new Legal, IP, and Regulatory path. 4. Provenance on regulatory-approval critical-path calendar after a QoE that cannot tie revenue to bank cash is broken; do not pick Proceed or Reprice yet.

ANALYSIS REQUIRED 1. Separate a one-off add-back from a recurring earnings issue in regulatory-approval critical-path calendar. 2. Map reps, earnout mechanics, and integration risk a roll-up of three regional service companies would inherit. 3. Tie quality-of-earnings, working-capital, and contingent items in regulatory-approval critical-path calendar to the carve-out is operable. 4. For this M&A Due Diligence Legal, IP, and Regulatory file, read regulatory-approval critical-path calendar against a QoE that cannot tie revenue to bank cash and write the one fact that would move the carve-out is operable for integration-risk PMO.

RECOMMENDATION Choose Proceed / Reprice / Walk / Hold on this M&A Due Diligence / Legal, IP, and Regulatory packet (regulatory-approval critical-path calendar after a QoE that cannot tie revenue to bank cash). Lead with the M&A Due Diligence option regulatory-approval critical-path calendar can support after a QoE that cannot tie revenue to bank cash, then the two facts that force it, then the Monday action for integration-risk PMO in a roll-up of three regional service companies.

COMMAND RETURNS - Bottom-line M&A Due Diligence option on the carve-out is operable, then the evidence in regulatory-approval critical-path calendar, then the action for integration-risk PMO - Hypothesis scorecard against regulatory-approval critical-path calendar: supported / rejected / untestable - Owner and next date for integration-risk PMO in a roll-up of three regional service companies - What changes the carve-out is operable if a QoE that cannot tie revenue to bank cash is later withdrawn